Global Artificial T- cell Receptors Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 - 2023

  • ID: 4315529
  • Report
  • Region: Global
  • 190 Pages
  • Occams Business Research and Consulting
1 of 4
Artificial T-Cell Receptors Market - Futuristic Application of Therapeutics Expecting 44% CAGR During 2016-2023

FEATURED COMPANIES

  • Adaptive Biotech
  • Elli Lilly
  • Kitepharma
  • Oxford Biomedica
  • Pontifax
  • Redmile Group
  • MORE

The global artificial T-cell receptors market is expected to grow with a CAGR of 44% during the forecast period 2016-2023. The increasing applications of artificial t cell receptors is one of the key factors adding growth in the global artificial T-cell receptors market. the artificial T cell receptors can control affinity of T cell receptors that increase its adoption in application such as drug discovery. Drug discovery is the key application for artificial T-cell receptors market. Personalized medicines have some biological content that allows them to be more effective and have less adverse effects that rises its demand for the treatment of chronic disorders such as cancer, etc.  The rising demand for personalized medicine is the key factor that is increasing the demand from drug and discovery application. Furthermore, increasing prevalence of chronic disorders such as cancer, cardiovascular disorders, etc. and increasing incidences of immunological disorders such as Chronic granulomatous disease is adding meaningful growth in global artificial T cell receptors market. As per WHO, by the end of 2020 there will be approx. $15 million people who are expected to have cancer which is rising by approximately 50%. According to Nation Cancer Institute, the breast cancer is one of the most common cancer in women across the globe. However, stringent government regulation and long duration of trials is restricting the growth of the global artificial T cell receptor market.

Geographically, North America held large market share in terms of revenue in 2016 in global  artificial t-cell receptors market,. Rapid rise in research and development (R&D) investment in artificial t-cell receptors by private players and governments across the globe is one of the key factor which is attributing towards the large share of North American market. Moreover, the presence of various key players such as Adaptive Biotech (US), Elli Lilly (US), Pfizer (US), etc. are also adding meaning full growth in the North America artificial T-cell receptors market. 

The growth in global artificial t-cell receptors market is also influenced by the presence of major players such as Adaptive Biotech (US), Elli Lilly (US), Juno therapeutics (US), Kitepharma (US), Lonza (Switzerland), Pfizer (US), Thermo Fisher Scientific (US), Precision Bioscience (US), etc. Product launches, Mergers & acquisitions etc. are some crucial strategies adopted by the major players to gain competitive advantage. 

The global artificial T-cell receptors market is segmented into application and end user. The application segment is segmented into assay, drug discovery, therapeutics and others. Moreover, the end user segment is further segmented into pharmaceuticals company, biotechnology company, research centers and others. Research center is expected to held largest market share in terms of revenue by the end of 2023. The growing demand for personalized medicine is resulting into the demand for artificial t cell receptors to perform clinical trials.



Note:
Please allow up to 72 hours for delivery.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Adaptive Biotech
  • Elli Lilly
  • Kitepharma
  • Oxford Biomedica
  • Pontifax
  • Redmile Group
  • MORE

1. Introduction
1.1. Executive Summary
1.2. Estimation Methodology

2. Market Overview
2.1. Global Artificial T-Cell Receptors Market: Evolution & Transition
2.2. Market Definition & Scope
2.3. Industry Structure
2.4. Regulatory Framework
2.5. Total Market Analysis
2.5.1. Top 5 Findings
2.5.2. Top 5 Opportunity Markets
2.5.3. Top 5 Companies
2.5.4. Top 3 Competitive Strategies
2.6. Estimation Analysis
2.7. Strategic Analysis
2.7.1. Investment Vs. Adoption Model
2.7.2. 360 Degree Industry Analysis
2.7.3. Porters 5 Force Model
2.7.4. See-Saw Analysis
2.7.5. Consumer Analysis And Key Buying Criteria
2.8. Competitive Analysis
2.8.1. Key Strategies & Analysis
2.8.2. Market Share Analysis & Top Company Analysis
2.9. Strategic Recommendations & Key Conclusions
2.9.1. Investment Opportunities By Regions
2.9.2. Opportunities in Emerging Applications
2.9.3. Investment Opportunity in Fastest Growing Segment

3. Market Determinants
3.1. Market Drivers
3.1.1. Increasing Prevalence of Chronic Disorders
3.1.2. Increasing Research And Development Spending On Oncology
3.1.3. Rising Application of T-Cell Receptors
3.1.4. Increasing Incidences of Immunological Disorders
3.2. Market Restraints
3.2.1. Stringent Government Regulation
3.2.2. Long Duration of Trials
3.3. Market Opportunities
3.3.1. Growing Demand from Emerging Countries
3.3.2. Development of Therapy for Hiv Infection
3.4.   Market Challenges
3.4.1. Lack of Skilled Professional
3.4.2. High Cost of Treatment

4. Market Segmentation
4.1. Global Artificial T-Cell Receptors Market By Application
4.1.1. Market Definition And Scope
4.1.2. Decision Support
4.1.3. Database & Estimation Methodology
4.1.4. Comparative Analysis Across Market Segments
4.1.5.  Opportunity Matrix
4.1.6. Market Segmentation
4.1.6.1. Global Artificial T-Cell Receptors Market in Assays
4.1.6.1.1. Adoption Scenario & Market Determinants
4.1.6.1.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.1.6.1.3. Top Players & Key Products
4.1.6.1.4. Key Conclusions
4.1.6.2. Global Artificial T-Cell Receptors Market in Drug Discovery
4.1.6.2.1. Adoption Scenario & Market Determinants
4.1.6.2.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.1.6.2.3. Top Players & Key Products
4.1.6.2.4. Key Conclusions
4.1.6.3. Global Artificial T-Cell Receptors Market in Therapeutic
4.1.6.3.1. Adoption Scenario & Market Determinants
4.1.6.3.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.1.6.3.3. Top Players & Key Products
4.1.6.3.4. Key Conclusions
4.1.6.4. Global Artificial T-Cell Receptors Market in Other Applications
4.1.6.4.1. Adoption Scenario & Market Determinants
4.1.6.4.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.1.6.4.3. Top Players & Key Products
4.1.6.4.4. Key Conclusions
4.2. Global Artificial T-Cell Receptors Market By End User
4.2.1. Market Definition And Scope
4.2.2. Decision Support Database & Estimation Methodology
4.2.3. Comparative Analysis Across Market Segments
4.2.4.  Opportunity Matrix
4.2.5. Market Segmentation
4.2.5.1. Global Artificial T-Cell Receptors in Pharmaceutical Companies
4.2.5.1.1. Application
4.2.5.1.2. Adoption Scenario & Market Determinants
4.2.5.1.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.2.5.1.4. Top Players & Key Products
4.2.5.1.5. Key Conclusions
4.2.5.2. Global Artificial T-Cell Receptors in Biotechnology Companies
4.2.5.2.1. Application
4.2.5.2.2. Adoption Scenario & Market Determinants
4.2.5.2.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.2.5.2.4. Top Players & Key Products
4.2.5.2.5. Key Conclusions
4.2.5.3. Global Artificial T-Cell Receptors in Research Centres
4.2.5.3.1. Application
4.2.5.3.2. Adoption Scenario & Market Determinants
4.2.5.3.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.2.5.3.4. Top Players & Key Products
4.2.5.3.5. Key Conclusions
4.2.5.4. Global Artificial T-Cell Receptors in Others
4.2.5.4.1. Application
4.2.5.4.2. Adoption Scenario & Market Determinants
4.2.5.4.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.2.5.4.4. Top Players & Key Products
4.2.5.4.5. Key Conclusions

5. Competitive Landscape
5.1. Key Strategies
5.1.1. List of Mergers & Acquisition
5.1.2. List of Joint Ventures
5.1.3. List of Product Launches
5.1.4. List of Partnerships

6. Geographical Analysis
6.1. Decision Support Database & Estimation Methodology
6.2. Comparative Analysis Across Market Segments
6.3. Opportunity Matrix
6.4.  Global Artificial T-Cell Receptors Market By Region 2014-2023 ($ Million)
6.4.1. North America
6.4.1.1. Industrial End-User Analysis 2014-2023 ($ Million)
6.4.1.2. Top Country Analysis
6.4.1.2.1. U.S.
6.4.1.2.1.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.1.2.1.2. Top Players & Key Products
6.4.1.2.1.3. Key Conclusions
6.4.1.2.2. Canada
6.4.1.2.2.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.1.2.2.2. Top Players & Key Products
6.4.1.2.2.3. Key Conclusions
6.4.2. Europe
6.4.2.1. Industry End-User Analysis 2014-2023 ($ Million)
6.4.2.2. Top Country Analysis
6.4.2.2.1. Uk
6.4.2.2.1.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.2.2.1.2. Top Players & Key Products
6.4.2.2.1.3. Key Conclusions
6.4.2.2.2. France
6.4.2.2.2.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.2.2.2.2. Top Players & Key Products
6.4.2.2.2.3. Key Conclusions
6.4.2.2.3. Germany
6.4.2.2.3.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.2.2.3.2. Top Players & Key Products
6.4.2.2.3.3. Key Conclusions
6.4.2.2.4. Spain
6.4.2.2.4.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.2.2.4.2. Top Players & Key Products
6.4.2.2.4.3. Key Conclusions
6.4.2.2.5. Rest of Europe
6.4.2.2.5.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.2.2.5.2. Top Players & Key Products
6.4.2.2.5.3. Key Conclusions
6.4.3. Asia Pacific
6.4.3.1. Industry End-User Analysis 2014-2023 ($ Million)
6.4.3.2. Top Country Analysis
6.4.3.2.1. China
6.4.3.2.1.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.3.2.1.2. Top Players & Key Products
6.4.3.2.1.3. Key Conclusions
6.4.3.2.2. India
6.4.3.2.2.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.3.2.2.2. Top Players & Key Products
6.4.3.2.2.3. Key Conclusions
6.4.3.2.3. Japan
6.4.3.2.3.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.3.2.3.2. Top Players & Key Products
6.4.3.2.3.3. Key Conclusions
6.4.3.2.4. Australia
6.4.3.2.4.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.3.2.4.2. Top Players & Key Products
6.4.3.2.4.3. Key Conclusions
6.4.3.2.5. Rest of Asia Pacific
6.4.3.2.5.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.3.2.5.2. Top Players & Key Products
6.4.3.2.5.3. Key Conclusions
6.4.4. Row
6.4.4.1. Industry End-User Analysis 2014-2023 ($ Million)
6.4.4.2. Top Country Analysis
6.4.4.2.1. Latin America
6.4.4.2.1.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.4.2.1.2. Top Players & Key Products
6.4.4.2.1.3. Key Conclusions
6.4.4.2.2. Middle East & Africa
6.4.4.2.2.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.4.2.2.2. Top Players & Key Products
6.4.4.2.2.3. Key Conclusions

7. Company Profiles
7.1. Adaptive Biotech
7.1.1. Overview
7.1.2. Product Portfolio
7.1.3. Key Innovation Sector
7.1.4. Strategic Initiatives
7.1.5. Scot Analysis
7.1.6. Strategic Analysis
7.2. Cell Medica
7.2.1. Overview
7.2.2. Product Portfolio
7.2.3. Key Innovation Sector
7.2.4. Strategic Initiatives
7.2.5. Scot Analysis
7.2.6. Strategic Analysis
7.3. Elli Lilly
7.3.1. Overview
7.3.2. Product Portfolio
7.3.3. Key Innovation Sector
7.3.4. Strategic Initiatives
7.3.5. Scot Analysis
7.3.6. Strategic Analysis
7.4. Juno Therapeutics
7.4.1. Overview
7.4.2. Product Portfolio
7.4.3. Key Innovation Sector
7.4.4. Strategic Initiatives
7.4.5. Scot Analysis
7.4.6. Strategic Analysis
7.5. Kitepharma
7.5.1. Overview
7.5.2. Product Portfolio
7.5.3. Key Innovation Sector
7.5.4. Strategic Initiatives
7.5.5. Scot Analysis
7.5.6. Strategic Analysis
7.6. Lonza
7.6.1. Overview
7.6.2. Product Portfolio
7.6.3. Key Innovation Sector
7.6.4. Strategic Initiatives
7.6.5. Scot Analysis
7.6.6. Strategic Analysis
7.7. Oxford Biomedica
7.7.1. Overview
7.7.2. Product Portfolio
7.7.3. Key Innovation Sector
7.7.4. Strategic Initiatives
7.7.5. Scot Analysis
7.7.6. Strategic Analysis
7.8. Pfizer
7.8.1. Overview
7.8.2. Product Portfolio
7.8.3. Key Innovation Sector
7.8.4. Strategic Initiatives
7.8.5. Scot Analysis
7.8.6. Strategic Analysis
7.9. Pontifax
7.9.1. Overview
7.9.2. Product Portfolio
7.9.3. Key Innovation Sector
7.9.4. Strategic Initiatives
7.9.5. Scot Analysis
7.9.6. Strategic Analysis
7.10. Precision Bioscience
7.10.1. Overview
7.10.2. Product Portfolio
7.10.3. Key Innovation Sector
7.10.4. Strategic Initiatives
7.10.5. Scot Analysis
7.10.6. Strategic Analysis
7.11. Redmile Group
7.11.1. Overview
7.11.2. Product Portfolio
7.11.3. Key Innovation Sector
7.11.4. Strategic Initiatives
7.11.5. Scot Analysis
7.11.6. Strategic Analysis
7.12. Seeking Alpha
7.12.1. Overview
7.12.2. Product Portfolio
7.12.3. Key Innovation Sector
7.12.4. Strategic Initiatives
7.12.5. Scot Analysis
7.12.6. Strategic Analysis
7.13. Thermo Fisher Scientific
7.13.1. Overview
7.13.2. Product Portfolio
7.13.3. Key Innovation Sector
7.13.4. Strategic Initiatives
7.13.5. Scot Analysis
7.13.6. Strategic Analysis
7.14. Unumrx
7.14.1. Overview
7.14.2. Product Portfolio
7.14.3. Key Innovation Sector
7.14.4. Strategic Initiatives
7.14.5. Scot Analysis
7.14.6. Strategic Analysis
7.15. Others
7.15.1. Overview
7.15.2. Product Portfolio
7.15.3. Key Innovation Sector
7.15.4. Strategic Initiatives
7.15.5. Scot Analysis
7.15.6. Strategic Analysis

List of Tables
1. Global Artificial T-Cell Receptors Market By Application 2014-2023 ($ Million)
2. Global Artificial T-Cell Receptors Market in Assays By Geography 2014-2023 ($ Million)
3. Global Artificial T-Cell Receptors Market in Drug Discovery By Geography 2014-2023 ($ Million)
4. Global Artificial T-Cell Receptors Market in Therapeutic By Geography 2014-2023 ($ Million)
5. Global Artificial T-Cell Receptors Market in Other Applications By Geography 2014-2023 ($ Million)
6. Global Artificial T-Cell Receptors Market By End User 2014-2023 ($ Million)
7. Global Artificial T-Cell Receptors in Pharmaceutical Companies By Geography 2014-2023 ($ Million)
8. Global Artificial T-Cell Receptors in Biotechnology Companies By Geography 2014-2023 ($ Million)
9. Global Artificial T-Cell Receptors in Research Centres By Geography 2014-2023 ($ Million)
10. Global Artificial T-Cell Receptors in Others By Geography 2014-2023 ($ Million)
11. North America Artificial T-Cell Receptors Market 2014-2023 ($ Million)
12. Europe Artificial T-Cell Receptors Market 2014-2023 ($ Million)
13. Asia Pacific Artificial T-Cell Receptors Market 2014-2023 ($ Million)
14. Rest of the World Artificial T-Cell Receptors Market 2014-2023 ($ Million)

List of Figures
1. Global Artificial T-Cell Receptors Market in Assays 2014-2023 ($ Million)
2. Global Artificial T-Cell Receptors Market in Drug Discovery 2014-2023 ($ Million)
3. Global Artificial T-Cell Receptors Market in Therapeutic 2014-2023 ($ Million)
4. Global Artificial T-Cell Receptors Market in Other Applications 2014-2023 ($ Million)
5. Global Artificial T-Cell Receptors in Pharmaceutical Companies 2014-2023 ($ Million)
6. Global Artificial T-Cell Receptors in Biotechnology Companies 2014-2023 ($ Million)
7. Global Artificial T-Cell Receptors in Research Centers 2014-2023 ($ Million)
8. Global Artificial T-Cell Receptors in Others 2014-2023 ($ Million)
9. United States (U.S.) Artificial T-Cell Receptors Market 2014-2023 ($ Million)
10. Canada Artificial T-Cell Receptors Market 2014-2023 ($ Million)
11. United Kingdom (Uk) Artificial T-Cell Receptors Market 2014-2023 ($ Million)
12. France Artificial T-Cell Receptors Market 2014-2023 ($ Million)
13. Germany Artificial T-Cell Receptors Market 2014-2023 ($ Million)
14. Spain Artificial T-Cell Receptors Market 2014-2023 ($ Million)
15. Roe Artificial T-Cell Receptors Market 2014-2023 ($ Million)
16. India Artificial T-Cell Receptors Market 2014-2023 ($ Million)
17. China Artificial T-Cell Receptors Market 2014-2023 ($ Million)
18. Japan Artificial T-Cell Receptors Market 2014-2023 ($ Million)
19. Australia Artificial T-Cell Receptors Market 2014-2023 ($ Million)
20. Roapac Artificial T-Cell Receptors Market 2014-2023 ($ Million)
21. Latin America Artificial T-Cell Receptors Market 2014-2023 ($ Million)
22. Mena Artificial T-Cell Receptors Market 2014-2023 ($ Million)

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Adaptive Biotech
  • Cell Medica
  • Elli Lilly
  • Juno Therapeutics
  • Kitepharma
  • Lonza
  • Oxford Biomedica
  • Pfizer
  • Pontifax
  • Precision Bioscience
  • Redmile Group
  • Seeking Alpha
  • Thermo Fisher Scientific
  • Unumrx
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll